14-Deoxyandrographolide
(Synonyms: 14-去氧穿心莲内酯) 目录号 : GC35057A diterpene lactone with diverse biological properties
Cas No.:4176-97-0
Sample solution is provided at 25 µL, 10mM.
14-Deoxyandrographolide is a diterpene lactone that has been found in A. paniculata and has diverse biological activities, including anticancer, hepatoprotective, antioxidative, and antidiabetic properties.1,2,3,4 It inhibits the growth of HL-60 cells with a GI50 value of 25.46 ?M and is cytotoxic to T47D cells (EC50 = 2.8 ?g/ml) but not HepG2 or NCI H23 cells (EC50s = 28.3 and 26.4 ?g/ml, respectively).1,2 14-Deoxyandrographolide (10 and 25 ?M) increases AMPK phosphorylation and glucose uptake in L6 myotubes and potentiates the effect of insulin to increase cell surface levels of GLUT4 in L6-GLUT4myc cells.4 It reduces blood glucose levels in rats in a model of streptozotocin-induced diabetes and in db/db diabetic mice when administered at a dose of 100 mg/kg. 14-Deoxyandrographolide reduces ethanol-induced hepatotoxicity in rats when administered at a dose of 15 mg/kg per day for the last four weeks of an eight-week ethanol exposure period.3 It also reduces protein carbonyl and thiobarbituric acid reactive substances (TBARS) levels and increases total glutathione (GSH) levels in isolated rat hepatocytes in the same model.
1.Chen, L., Zhu, H., Wang, R., et al.ent-Labdane diterpenoid lactone stereoisomers from Andrographis paniculataJ. Nat. Prod.71(5)852-855(2008) 2.Tan, M.L., Kuroyanagi, M., Sulaiman, S.F., et al.Cytotoxic Activities of Major Diterpenoid Constituents of Andrographis paniculata. in a Panel of Human Tumor Cell LinesPharmaceutical Biology43(6)501-508(2008) 3.Mandal, S., Nelson, V.K., Mukhopadhyay, S., et al.14-Deoxyandrographolide targets adenylate cyclase and prevents ethanol-induced liver injury through constitutive NOS dependent reduced redox signaling in ratsFood. Chem. Toxicol.59236-248(2013) 4.Arha, D., Pandeti, S., Mishra, A., et al.Deoxyandrographolide promotes glucose uptake through glucose transporter-4 translocation to plasma membrane in L6 myotubes and exerts antihyperglycemic effect in vivoEur. J. Pharmacol.768207-216(2015)
Cas No. | 4176-97-0 | SDF | |
别名 | 14-去氧穿心莲内酯 | ||
Canonical SMILES | O=C1OCC=C1CC[C@@H]2C(CC[C@]3([H])[C@](C)(CO)[C@H](O)CC[C@@]23C)=C | ||
分子式 | C20H30O4 | 分子量 | 334.45 |
溶解度 | DMSO : 100 mg/mL (299.00 mM; Need ultrasonic) | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.99 mL | 14.9499 mL | 29.8998 mL |
5 mM | 0.598 mL | 2.99 mL | 5.98 mL |
10 mM | 0.299 mL | 1.495 mL | 2.99 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet